APA (7th ed.) Citation

Carter, C. A., Rajan, A., Keen, C., Szabo, E., Khozin, S., Thomas, A., . . . Salgia, R. (2016). Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer. Annals of Oncology, 27(4), 693. https://doi.org/10.1093/annonc/mdw008

Chicago Style (17th ed.) Citation

Carter, C. A., et al. "Selumetinib with and Without Erlotinib in KRAS Mutant and KRAS Wild-type Advanced Nonsmall-cell Lung Cancer." Annals of Oncology 27, no. 4 (2016): 693. https://doi.org/10.1093/annonc/mdw008.

MLA (9th ed.) Citation

Carter, C. A., et al. "Selumetinib with and Without Erlotinib in KRAS Mutant and KRAS Wild-type Advanced Nonsmall-cell Lung Cancer." Annals of Oncology, vol. 27, no. 4, 2016, p. 693, https://doi.org/10.1093/annonc/mdw008.